Global Respiratory Monitoring and Therapeutic Devices Market Report 2022: Future Growth Potential of Respiratory Devices due to Their Rising Demand in Home Care Settings
This study examines the respiratory device market and includes respiratory monitoring and therapeutic devices. Respiratory device end users, including hospitals, physician offices, nursing homes, sleep laboratories, ambulatory surgical centers, and home care settings, are considered for this study.
The COVID-19 pandemic significantly increased the demand for respiratory devices, such as ventilators, oxygen concentrators, and pulse oximeters. In addition, home care device demand rose due to the growing burden on healthcare resources, and it is estimated to drive the respiratory device market.
Across the world, more than 900, 330, and 380 million people suffer from sleep apnea, asthma, and chronic obstructive pulmonary disorder, respectively, and this high disease burden drives the respiratory monitoring device market. Although the prevalence of different chronic respiratory diseases is high, a large population pool is undiagnosed, especially in South Asia, Latin America, and Africa. Public and private organization initiatives are estimated to increase awareness, diagnosis, and treatment rates.
Patient adherence is a major challenge, and respiratory monitoring device industry vendors are developing various software platforms and apps to address it, increase patient engagement, and provide education related to therapies and disease management.
In addition, key stakeholders are introducing technologically advanced devices, such as wearables, artificial intelligence (AI)-/machine learning (ML)-integrated devices, and connected devices, to increase patient adoption. Respiratory devices are continuously modified to be portable, small, connected, and smart. These technological advancements are estimated to drive market growth potential.
In addition, the report includes the following:
Market size by revenue, covering historic and forecast data by segment (PAP devices, oxygen concentrators, capnography devices, spirometers, polysomnography devices, pulse oximeters, and peak flow meters) and region (North America, Europe, and Asia-Pacific)
Challenges and drivers
Competitive landscape, including company market share
Future trends and growth opportunities for stakeholders
Key Topics Covered:
1. Strategic Imperatives
Why is it Increasingly Difficult to Grow?
The Strategic Imperative
The Impact of the Top 3 Strategic Imperatives on Respiratory Monitoring Solutions
Growth Opportunities Fuel the Growth Pipeline Engine
2. Growth Opportunity Analysis
Scope of Analysis
Segmentation
Respiratory Devices by Disease Areas
Respiratory Devices - Care Pathway
Respiratory Disease Burden
Respiratory Devices - End Users
Home Care Settings by Product Type
Respiratory Devices - Trends
Respiratory Monitoring Technology Evolution
Respiratory Devices - Key Competitors
Respiratory Monitoring Devices - Key Competitors
Respiratory Therapeutic Devices - Key Competitors
Growth Metrics
Growth Drivers
Growth Restraints
Forecast Assumptions
Revenue Forecast
Revenue Forecast by Product
Revenue Forecast by Region
Revenue Forecast Analysis
Regional Market
Pricing Trends and Forecast Analysis
Competitive Environment
Revenue Share
Revenue Share Analysis
Company Mapping
Company Mapping by Technology Adoption
Monitoring Wearables
Mobile Applications and Software Platforms
3. Growth Opportunity Analysis - PAP Devices
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Forecast Analysis - Patients Waiting for Sleep Apnea Therapy
About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Voxtur Analytics Corp. , a North American technology company creating a more transparent and accessible real estate lending ecosystem, is pleased to announce that it has engaged the services of ICP Securities Inc. ("ICP") to provide automated market...
On April 19, 2024, the board of directors of Portland General Electric Company declared a quarterly common stock dividend of $0.50 per share, representing an increase of 5.3%, or $0.10 per share, on an annualized basis.
The company's dividend is...
Adyton Resources Corporation ("Adyton" or the "Company") announces it has closed its previously announced non-brokered private placement offering, pursuant to which it has issued 50,000,000 common shares of the Company ("Shares") at a price of...
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...
Lion Group Holding Ltd. ("Lion" or "the Company") , the operator of an all-in-one trading platform that offers a wide spectrum of products and services, today announced that on April 18, 2024, it received a delinquency notification letter from the...
Cosmos Health Inc. ("Cosmos Health" or the "Company'') , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor...